Despite the high stakes, more than half of boards and CEOs are not confident their succession planning is adequate.

How pharma and biotech leaders can navigate today’s challenging landscape—focusing on revamped approaches in business operations, talent strategy and development, and more to meet the evolving demands.

Outlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.

When things go wrong, efforts to hold people “accountable” in an organization rarely produce what leaders actually want. Instead, they see compliance without commitment and weakened performance over time. The core issue is: Accountability cannot be mandated; it must be chosen.

La adopción acelerada de la IA impulsa la innovación, pero también abre la puerta a filtraciones de datos y riesgos de ciberseguridad. En su reciente entrevista para el medio, Isaac Cantalejo advierte del peligro de esta nueva “amenaza” digital

Un análisis sobre los desafíos de la comunicación empresarial, el liderazgo y las tendencias que están marcando el entorno económico y corporativo actual.

‍